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Abstract
Urinary tract infections (UTI), which are mostly caused by Escherichia coli, are an important public health problem worldwide. Although men
experience diverse UTI syndromes, there have been relatively few molecular-epidemiological studies of UTI pathogenesis in men. We
studied the distribution of 22 E. coli virulence factor (VF) genes, major phylogenetic groups, sequence type ST131, and UTI-associated O
antigens among 101 pyelonephritis, 153 cystitis and 135 fecal healthy control E. coli isolates from men aged 30–70 years in a regional area of
NSW, Australia. Overall, the studied traits exhibited a prevalence gradient across these groups, highest in pyelonephritis, intermediate in
cystitis, and lowest among fecal isolates. Differences in virulence gene prevalence between cystitis and pyelonephritis isolates were limited
to eight genes. The UTI-associated O antigens were also distributed widely, but types O6, O25 and O75 were signiﬁcantly associated with
pyelonephritis. The ST131 clonal group, which accounted for 13% of isolates overall (22% of group B2 isolates), likewise exhibited a
signiﬁcant descending prevalence gradient from pyelonephritis (36%), through cystitis (8%), to fecal (0%) isolates. These ﬁndings contribute
to better understanding of the pathogenesis of UTIs in men and identify speciﬁc VF genes and O types, and a prominent clonal group
(ST131), as being important in UTI pathogenesis in this population.
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Introduction
Urinary tract infections (UTIs), which are among the com-
monest bacterial diseases of humans, are responsible for
considerable morbidity, mortality and healthcare costs world-
wide [1]. Better understanding of their pathogenesis is needed,
to guide the development of preventive measures.
Most UTIs are caused by Escherichia coli, a normal constit-
uent of the intestinal microbiota [2]. The distinctive E. coli
strains that cause most UTIs have been designated uropath-
ogenic E. coli. They possess diverse virulence-associated fac-
tors (VFs) that assist them in attaching to, invading, and injuring
the host, and include adhesins, toxins, siderophores, protec-
tive polysaccharide coatings, invasins, and serum resistance-
associated proteins. The presence and numbers of such VFs
predicts in vivo virulence [3].
Most studies, comparing the distribution of VFs among
E. coli isolates from different uroclinical syndromes, and fecal
isolates, have focused on women and girls, among whom UTI is
most common [2,4]. However, men also experience UTIs,
including cystitis, pyelonephritis, prostatitis, and febrile UTI
[5,6]. As a consequence, studies of the E. coli strains that cause
UTI in men are needed.
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The few such studies available date to 2007 or earlier, and
involved small sample sizes, a restricted range of VF genes
analysed, lack of consideration for phylogenetic and clonal
groups (including the recently emerged disseminated clonal
group sequence type ST131), or pooled data from men and
women. The speciﬁc characteristics of uropathogenic E. coli
from men, especially in the current era, therefore remain
incompletely deﬁned.
We compared the distributions of VF genes, phylogenetic
groups, ST131, and UTI-associated O antigens among three
groups of recent E. coli isolates, including urinary isolates from
men with uncomplicated cystitis or pyelonephritis and fecal
isolates from healthy controls, with efforts to avoid interfer-
ence from the confounding effect of host compromise.
Materials and Methods
Study design
This prospective study, which involved 11 regional hospitals
and 23 outpatient centres, in the central west region of New
South Wales, Australia (human population, 180 000), was
conducted in conjunction with physicians in the participating
centres. Hospitalized patients were not included. Each partic-
ipating physician received a protocol on urine collection, and
the diagnostic criteria for cystitis or pyelonephritis. In addition
to performing physical examination of patients, physicians
collected and reported anonymously, the following informa-
tion for patients with UTI (deﬁned below): age, clinical UTI
diagnosis, previous UTI and known underlying host conditions.
E. coli isolates and study subjects
Contemporaneous E. coli isolates from 288 men, with UTI,
one per subject, were collected at the participating centres
over a 2-year period (June 2009 to June 2011). The subjects
had cystitis (n = 153), or pyelonephritis (n = 101). Subjects
were aged from 30 to 70 years, with a median age of 47 years.
A diagnosis of cystitis or pyelonephritis required speciﬁc
manifestations, as recorded by the treating medical practi-
tioner, and a midstream urine culture yielding  108 CFU/L of
E. coli. Cystitis-deﬁning manifestations included dysuria, fre-
quent urination, and suprapubic tenderness, without fever or
loin pain. Pyelonephritis-deﬁning manifestations included uri-
nary symptoms plus, fever of  38°C and ﬂank pain, with or
without nausea/vomiting. Patients with diabetes and known
urinary tract abnormalities were excluded.
Urinary tract abnormality was deﬁned based on the attend-
ing physician’s assessment at the time of the index patient
encounter. Urological evaluation to exclude inapparent struc-
tural or functional genitourinary abnormalities was not done.
During the same 2-year period, fecal isolates were collected
from 135 consenting male volunteers (30–70 years old) who,
according to self-report, lacked UTI-associated manifestations.
These controls were matched with UTI patients by age and, as
closely as possible, by place of residence within the region.
Control participants provided written informed consent and a
rectal swab, which was processed within 10 h of collection.
One arbitrarily chosen E. coli colony per specimen was studied
[7].
Ethics approval
The Sydney West Area Health Service Human Ethics Research
Committee and Charles Sturt University Ethics Committee
approved the study protocol. Guidelines for experimentation
at the authors’ institutions were followed in the conduct of
this clinical research. As clinical information for patients with
UTI was collected anonymously, patient consent was not
obtained.
Urine culture
Clinical staff at the participating healthcare centres collected
the urine specimens, using a provided standardized protocol.
Semi-quantitative culture was performed on horse blood,
MacConkey and chromogenic agars, followed by conventional
identiﬁcation. The E. coli isolates were stored in 5% glycerol in
trypticase soy broth at 70°C.
Virulence factor genes
Twenty-two VF genes (Table 1) were identiﬁed using a
multiplex PCR reverse line-blot hybridization assay [8]. The
aggregate VF score for an isolate was the number of unique
VFs detected, counting multiple pap operon genes as one. Such
molecular characteristics predict experimental virulence in vivo
[3].
Phylogenetic grouping, ST131 detection and O typing
Major E. coli phylogenetic groups (A, B1, B2 and D) were
identiﬁed by triplex PCR [9]. Group B2 isolates were screened
for ST131 by PCR-based detection of ST131-speciﬁc single
nucleotide polymorphisms in mdh and gyrB [10,11]. PCR-based
O (somatic antigen) typing was used to detect 12 UTI-
associated O types: O1, O2, O4, O6, O7, O12, O15, O16,
O17, O18, O25 and O75 [10]. ST131 isolates exhibiting O-
type 25 were further characterized as O25a versus O25b by
variant-speciﬁc PCR [11,12].
Quality control
All molecular testing was performed in duplicate using
independently prepared DNA lysates of the test strain and
appropriate positive and negative controls.
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Statistical analysis
Comparisons of proportions were tested using Fisher’s exact
test. Virulence score comparisons were tested using the Mann–
Whitney U-test. The signiﬁcance criterion was p <0.05.
Results
VF gene distribution by source group
Among the 389 total E. coli isolates, the prevalence of
individual VF genes, within the three source groups, ranged
from 0% (bmaE, gafD, kpsMTIII) to 97% (ﬁmH) (Table 1).
Nineteen VF genes were detected in at least one isolate per
source group, the exceptions being bmaE, gafD and kpsMTIII,
which were absent from fecal isolates. The most frequently
encountered VF genes overall were ﬁmH, fyuA, ompT, papEF,
traT, iutA, usp, hlyA and iroN ( 55% each).
Compared with cystitis and pyelonephritis isolates, fecal
isolates exhibited a signiﬁcantly lower prevalence of 20 VF
genes (Table 1). Apart from ﬁmH (88%), only four genes (traT,
papE, papC and papAH) occurred in >30% of fecal isolates.
Accordingly, VF scores were much lower among fecal isolates
than cystitis and pyelonephritis isolates (Fig. 1).
In contrast, differences between cystitis and pyelonephritis
isolates for VF gene prevalence were conﬁned to eight genes
TABLE 1. Distribution of virulence-associated genes by source among 389 Escherichia coli isolates from men with cystitis or
pyelonephritis and healthy controls
Functional category Trait/gene
Prevalence, no. (column %) p valuea
Total
(n = 389)
Fecal
(n = 135)
Cystitis
(n = 153)
Pyelob
(n = 101) Fecal vs cystitis Fecal vs pyelo Pyelo vs cystitis
Adhesins afa/draBC 33 (8) 1 (1) 17 (11) 15 (15) <0.001 <0.001 NSc
bmaE 2 (0.5) 0 (0) 0 (0) 2 (2) NS NS NS
sfaS 73 (19) 10 (7) 40 (26) 23 (23) <0.001 0.001 NS
ﬁmH 363 (93) 119 (88) 147 (96) 97 (97) 0.014 0.035 NS
focG 151 (39) 6 (4) 89 (58) 56 (56) <0.001 <0.001 NS
papGI 14 (4) 1 (1) 9 (6) 4 (4) 0.022 NS NS
papGII 115 (30) 15 (11) 47 (30) 53 (53) <0.001 <0.001 <0.001
papGIII 97 (25) 13 (10) 43 (28) 41 (41) <0.001 <0.001 0.042
papGI + III 6 (1.5) 0 (0) 5 (3) 1 (1) NS NS NS
papGII + III 22 (6) 0 (0) 12 (8) 10 (10) <0.001 <0.001 NS
papGI + II + III 3 (1) 0 (0) 2 (1) 1 (1) NS NS NS
papAH 213 (55) 41 (30) 93 (61) 79 (79) <0.001 <0.001 0.004
papC 220 (57) 45 (33) 93 (61) 82 (82) <0.001 <0.001 <0.001
papEF 233 (60) 49 (35) 97 (63) 87 (87) <0.001 <0.001 <0.001
gafD 4 (1) 0 (0) 2 (1) 2 (2) NS NS NS
Toxins cnf1 177 (46) 14 (10) 80 (52) 83 (83) <0.001 <0.001 <0.001
hlyA 214 (55) 25 (19) 113 (74) 76 (76) <0.001 <0.001 NS
Siderophores iutA 232 (60) 21 (16) 127 (83) 84 (84) <0.001 <0.001 NS
fyuA 254 (65) 36 (27) 127 (83) 91 (91) <0.001 <0.001 NS
iroN 222 (57) 25 (19) 115 (75) 82 (82) <.001 <0.001 NS
Protectins kpsMT II 201 (52) 24 (18) 101 (66) 76 (76) <0.001 <0.001 NS
kpsMT III 35 (9) 0 (0) 18 (12) 17 (17) <0.001 <0.001 NS
traT 252 (65) 43 (32) 125 (82) 84 (84) <0.001 <0.001 NS
ompT 227 (58) 25 (19) 113 (74) 89 (89) <0.001 <0.001 0.007
Bacteriocin usp 222 (57) 31 (23) 107 (70) 84 (84) <0.001 <0.001 0.018
ap values (by Fisher’s exact test) are shown where p <0.05 comparing cystitis with fecal isolates. The 22 virulence factors analysed were; papA, P ﬁmbriae structural subunit; papC,
p ﬁmbriae assembly; papEF, ﬁmbriae tip pilins; papG, p ﬁmbriae adhesin (and alleles I, II, and III); sfaS, S ﬁmbriae; focG, F1C ﬁmbriae; afa/draBC, Dr-binding adhesins; ﬁmH, type 1
ﬁmbriae; hlyA, haemolysin; cnf1, cytotoxic necrotizing factor type 1; fyuA, ferric yersiniabactin receptor; iutA, aerobactin receptor; iron, salmochelin receptor; kpsM II, group 2
capsule (with K1 and K2 variants); kpsMT III, group 3 capsule; traT, serum-resistance associated; ompT, outer membrane protein T (protease); bmaE, M ﬁmbriae; gafD, G ﬁmbriae.
bPyelo, pyelonephritis.
cNS, not signiﬁcant (p  0.05).
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FIG. 1. Distribution of virulence factor (VF) scores among 389
Escherichia coli isolates from men with cystitis or pyelonephritis and
healthy controls. The coloured columns indicate, for each source group,
the percentage of isolates (y-axis) with a given VF score (x-axis). Median
VF scores (range), by group: fecal, 3 (0–13); cystitis 7 (1–14); pyelone-
phritis 9 (1–16). p values for fecal versus cystitis, fecal versus pyelone-
phritis, cystitis versus pyelonephritis: p  0.001 for all comparisons.
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(papAH, papC, papEF, papGII, papGIII, cnf1, ompT and usp), all of
which were more common among pyelonephritis isolates.
Accordingly, pyelonephritis isolates had signiﬁcantly higher
median virulence scores (p <0.001) (Fig. 1).
Phylogenetic groups
Of the 389 isolates, 225 (58%) belonged to group B2, followed by
groups A (21%), D (16%) and B1 (6%) (Table 2). Group B2
dominatedamongclinical isolates (70%), but accounted foronly 34%
of fecal isolates (p <0.001), among which group A was the most
prevalent (42% versus 9%). Phylogenetic group distribution did not
differ signiﬁcantly between the cystitis and pyelonephritis isolates.
Distribution of VF genes by phylogenetic group and source
Overall, most VF genes were most prevalent among group B2
isolates, followed by group D isolates (Table 3). Accordingly,
VF scores followed a descending gradient, from group B2,
through group D to groups A and B1 (Table 4).
To clarify the relationship between phylogenetic groups and
VF genes, VF scores were compared among the four
phylogenetic groups, stratiﬁed by source group, and among
the source groups, stratiﬁed by phylogenetic group (Table 4).
There was a descending VF score gradient from pyelonephritis,
through cystitis, to fecal isolates and, within each source
group, from phylogenetic groups B2, through group D to
groups A and B1 (Table 4). Increments in VF score between
source groups (within a given phylogenetic group) were similar
in magnitude to those between phylogenetic groups (within a
given source group). Consequently, VF scores were highest
among group B2 pyelonephritis isolates (median, 14), lowest
among group A and B1 fecal isolates (median, 2), and
intermediate (but quite similar) among group A and B1
TABLE 2. Distribution of phylogenetic groups and sequence type ST131 among 389 Escherichia coli isolates from men with
cystitis or pyelonephritis and healthy controls
Phylogenetic/clonal group
Prevalence, no. (column %) p valuea
Total
(n = 389) Fecal (n = 135) Cystitis (n = 153) Pyelob (n = 101) Fecal vs cystitis Fecal vs pyelo Pyelo vs cystitis
A 80 (21) 57 (42) 15 (10) 8 (8) <0.001 <0.001 NSc
B1 24 (6) 12 (9) 8 (5) 4 (4) NS NS NS
B2 225 (58) 46 (34) 104 (68) 75 (75) <0.001 <0.001 NS
D 63 (16) 24 (18) 26 (17) 13 (13) NS NS NS
ST131d 49 (13) 0 (0) 13 (8) 36 (36) <0.001 <0.001 <0.001
O25b ST131e 44 (11) 0 (0) 13 (8) 31 (31) <0.001 <0.001 <0.001
O16 ST131e 5 (1) 0 (0) 0 (0) 5 (5) NS 0.014 0.014
ap values (by Fisher’s exact test) are shown where p <0.05.
bPyelo, pyelonephritis.
cNS, not signiﬁcant (p  0.05).
dST131, sequence type 131: a subset of phylogenetic group B2.
eO25b and O16, the corresponding – O-type-based subsets of ST131.
TABLE 3. Phylogenetic group distribution of virulence genes among 389 Escherichia coli isolates from men with cystitis or
pyelonephritis and healthy controls
Virulence gene
Prevalence of gene, no. (column %) p valuea
A (n = 80) B1 (n = 24) B2 (n = 225) D (n = 63) B2 vs D B2 vs A & B1
afa/dra 4 (5) 0 (0) 27 (12) 2 (3) NSb <0.001
bmaE 0 (0) 0 (0) 2 (1) 0 (0) NS NS
sfaS 0 (0) 1 (4) 67 (30) 5 (8) <0.001 <0.001
ﬁmH 60 (75) 18 (75) 223 (99) 62 (99) NS NS
focG 2 (2) 1 (3) 52 (23) 2 (3) <0.001 <0.001
papGI 0 (0) 0 (0) 13 (6) 1 (2) NS <0.001
papGII 0 (0) 0 (0) 99 (44) 15 (24) <0.001 <0.001
papGIII 0 (0) 1 (1) 90 (40) 6 (9) <0.001 <0.001
papAH 8 (10) 1 (3) 163 (72) 41 (65) NS <0.001
papC 9 (11) 1 (5) 170 (76) 40 (63) NS <0.001
papEF 10 (13) 2 (8) 182 (81) 39 (62) 0.002 <0.001
gafD 0 (0) 0 (0) 4 (16) 0 (0) <0.001 <0.001
cnf1 0 (0) 1 (3) 157 (70) 19 (31) <0.001 <0.001
hlyA 3 (4) 1 (5) 185 (82) 25 (40) <0.001 <0.001
iutA 14 (18) 2 (8) 173 (76) 43 (68) NS <0.001
fyuA 11 (14) 4 (17) 205 (91) 34 (54) <0.001 <0.001
iroN 8 (10) 8 (33) 172 (76) 34 (53) 0.002 <0.001
traT 20 (25) 3 (13) 180 (80) 49 (77) NS <0.001
kpsMT II 2 (2) 1 (4) 171 (75) 20 (32) <0.001 <0.001
kpsMT III 0 (0) 0 (0) 23 (10) 0 (0) <0.001 <0.001
ompT 5 (6) 8 (33) 188 (84) 31 (49) <0.001 <0.001
usp 1 (1) 4 (17) 185 (82) 32 (51) <0.001 <0.001
ap values (by Fisher’s exact test) are shown where p <0.05.
bNS, not signiﬁcant (p  0.05).
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pyelonephritis isolates, group D cystitis isolates, and group B2
fecal isolates (medians, 5–6) (Table 4).
O types
Overall, the most commonly identiﬁed O types, in descending
rank order, were O2, O25, O16 and O6 (>10% of isolates
each) (Table 5). A signiﬁcantly higher proportion of fecal (32%)
than cystitis (18%) or pyelonephritis (14%) isolates, belonged
to none of the deﬁned uropathogenic E. coli-related O-types.
Nine of the deﬁned O types were signiﬁcantly distributed by
source group. Most of these were signiﬁcantly more prevalent
among cystitis and/or pyelonephritis isolates than fecal isolates
(e.g. O6, O16, O25, O25b and O75), whereas others were
signiﬁcantly more prevalent among fecal isolates (O4), cystitis
isolates (O12, O15), or cystitis and fecal isolates (O7) than
among pyelonephritis isolates.
Prevalence and clinical correlates of ST131
Forty-nine (22%) of the 225 group B2 isolates belonged to
ST131 (Table 2). ST131 was strongly associated with clinical
source, exhibiting a marked descending prevalence gradient
from pyelonephritis (36%), through cystitis (8%) to fecal (0%).
A similar (albeit less marked) source-related ST131 prevalence
gradient was apparent even among group B2 isolates. Specif-
ically, of the 225 group B2 isolates, 36 (16%) were ST131
isolates from pyelonephritis cases, compared with 13 (6%)
from cystitis and 0 (0%) from fecal isolates.
According to O-type PCR, 44 (90%) of the 49 ST131
isolates were O25b and ﬁve (10%) were O16 (Table 2).
Interestingly, all ﬁve (100%) of the O16 ST131 isolates were
pyelonephritis isolates compared with 70% of the O25b ST131
isolates.
Discussion
In this molecular-epidemiological study, we examined the
distribution of VF genes, phylogenetic groups, ST131 status
and UTI-associated O types among E. coli isolates from men
with cystitis or pyelonephritis and healthy controls. We
TABLE 5. Distribution of various O types by source among 389 Escherichia coli isolates from men with cystitis or pyelonephritis
and healthy controls
O type
Prevalence of O type, no. (column %) p valuea
Total (n = 389) Fecal (n = 135) Cystitis (n = 153) Pyelob (n = 101) Fecal vs cystitis Fecal vs pyelo Cystitis vs pyelo
O1 17 (4) 4 (3) 8 (5) 5 (5) NSc NS NS
O2 55 (14) 20 (15) 18 (12) 17 (17) NS NS NS
O4 11 (3) 11 (8) 0 (0) 0 (0) <0.001 0.003 NS
O6 37 (10) 8 (6) 8 (6) 15 (15) NS 0.027 0.012
O7 17 (4) 8 (6) 9 (6) 0 (0) NS 0.011 0.013
O12 26 (7) 7 (5) 18 (12) 1 (1) NS NS 0.001
O15 7 (2) 1 (1) 6 (4) 0 (0) NS NS NS
O16 41 (11) 4 (3) 23 (15) 14 (14) <0.001 <0.001 NS
O17 14 (4) 9 (7) 5 (3) 0 (0) NS 0.011 NS
O18 11 (3) 4 (3) 6 (4) 1 (1) NS NS NS
O25 48 (12) 3 (2) 14 (9) 31 (31) NS <0.001 <0.001
O25a 2 (<1) 0 (0) 1 (1) 1 (1) NS NS NS
O25b 46 (12) 0 (0) 13 (8) 33 (33) <0.001 <0.001 <0.001
O75 22 (6) 4 (3) 5 (3) 13 (13) NS 0.005 0.005
Untypable 85 (24) 43 (32) 28 (18) 14 (14) 0.009 0.002 NS
ap values (by Fisher’s exact test) are shown where p <0.05.
bPyelo, pyelonephritis.
cNS, not signiﬁcant (p  0.05).
TABLE 4. Distribution of aggregate virulence factor (VF) scores by phylogenetic group and source among 389 Escherichia coli
isolates from men
Phylogenetic group
Aggregate VF score, median (range) p valuea
Total Fecal Cystitis Pyelob Fecal vs cystitis Fecal vs pyelo Cystitis vs pyelo Fecal vs (cystitis + pyelo)
A (n = 80) 4 (0–10) 2 (0–5) 4 (1–9) 6 (1–10) NSc <0.001 0.03 <0.001
B1 (n = 24) 4 (0–8) 2 (0–5) 4 (1–8) 5 (3–8) NS <0.001 NS <0.001
B2 (n = 225) 9 (3–16) 6 (3–13) 9 (5–14) 14 (8–16) <0.001 <0.001 <0.001 <0.001
D (n = 63) 7 (2–13) 4 (2–11) 6 (3–11) 9 (5–13) 0.02 <0.001 <0.001 <.0 001
ap values by Mann–Whitney test are shown where p <0.05.
bPyelo, pyelonephritis.
cNS, not signiﬁcant (p  0.05).
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documented numerous syndrome-speciﬁc differences in the
distribution of many of these traits, but conservation across
source groups for others, particularly the most prevalent VFs.
Overall, compared with fecal isolates, pyelonephritis and
cystitis isolates contained more VF genes, and were more
likely to belong to UTI-associated O types, phylogenetic group
B2 and ST131.
The identiﬁed syndrome-speciﬁc differences among E. coli
clinical and fecal isolates from men are consistent with
ﬁndings from other studies, mostly involving women, which
have shown a gradient of virulence from E. coli strains
causing more invasive UTI syndromes, such as pyelonephritis
and febrile UTI, through those causing cystitis to fecal
strains [2,13]. However, compared with many studies in
women, including our own, in the same geographic area and
time period [8], the present cystitis isolates appear more
virulent and closer to the pyelonephritis isolates, and farther
from the fecal isolates. This suggests that men are less likely
than women or girls to develop cystitis because of low-
virulence strains, which is consistent with a previous
observation that isolates from men with febrile UTI
appeared relatively virulent, even in the presence of host
compromise [14].
Of the three source groups, the pyelonephritis isolates
exhibited the highest prevalences of many individual VFs, had
the highest VF scores, and, were the most likely to belong to
phylogenetic group B2, ST131 and a UTI-associated O type.
Eight VF genes were signiﬁcantly more prevalent among
pyelonephritis than cystitis isolates, including ﬁve from the pap
operon (papAH, papC, papEF, papGII, papGIII) and three that
encode non-adhesin traits, including a toxin (cnf1), an outer
membrane protease (ompT), and a bacteriocin (usp). Most of
these genes have also been associated with pyelonephritis in
females [15–17], and conceivably could be targets for inter-
ventions against pyelonephritis in males.
The higher prevalence of pap operon genes (encoding P
ﬁmbriae) in pyelonephritis than in cystitis isolates is in agree-
ment with previous ﬁndings [15,17] and correlates with
increased tropism, for the kidney, of P ﬁmbriated strains. papGII
has also been shown, experimentally to contribute to the
pathogenesis of pyelonephritis [18,19], and ompT is strongly
associated with febrile UTI in men [6,14]. However, it is not
clear whether these VFs act individually or in concert with other
known or unknown VFs in causing pyelonephritis. Additionally,
although these ﬁndings suggest that cystitis can be caused by less
virulent strains than those causing pyelonephritis, they could
also mean that other VF genes, not included in the present study,
are speciﬁcally associated with cystitis in men. Also, the simple
presence/absence of VFs may be insufﬁcient to deﬁne
differences in virulence between strains. Notably, we did not
explore other factors, such as VF gene polymorphisms [20,21],
and variations in ﬁmH sequences [20,21] or ﬁm operon
regulation [22], that also play a role in UTI pathogenesis.
Despite differences in VF gene prevalence values and VF
scores, phylogenetic group distribution did not differ signiﬁ-
cantly between pyelonephritis and cystitis isolates. However,
within each phylogenetic group, VF scores exhibited a gradient
across source groups, implying the presence of source group-
speciﬁc subsets with different levels of virulence. This agrees
with previous work [16] and suggests that VF repertoire is as,
or more, important than phylogenetic background for pre-
dicting pathogenic behavior in extraintestinal E. coli.
Escherichia coli ST131, within virulence-associated phyloge-
netic group B2, has emerged recently as a globally dissemi-
nated cause of multidrug-resistant extraintestinal infections in
humans and companion animals, including in Australia [23]. To
our knowledge, the prevalence of ST131 in different types of
UTI has not been assessed previously, even among women and
girls, let alone men.
Here we report two novel ﬁndings regarding ST131. First,
ST131 exhibited a marked prevalence gradient across source
groups, accounting for 36% of pyelonephritis and 8% of cystitis
isolates (p <0.001), but no fecal isolates (p <0.01), consistent
with increased urovirulence, compared with other E. coli. This
provides to our knowledge, the ﬁrst epidemiological evidence
of increased virulence for ST131, which has been presumed
but is not supported by available evidence from experimental
animal models [24,25]. ST131 is associated with CTX-M-15
extended-spectrum b-lactamase production, which makes it
resistant to extended cephalosporins. The resistance advan-
tage, in combination with the possible presence of enhanced
virulence, could explain the recent worldwide emergence of
ST131.
Second, although most ST131 isolates exhibited the O25b
rfb variant, as expected, a substantial minority exhibited type
O16, and this subset (which, notably, would not be detected
by screening for the O25b rfb variant) [26] was conﬁned to
pyelonephritis, suggesting an enhanced ability to cause kidney
infection. Further studies of ST131, including, speciﬁcally, its
O25b and (newly reported here) O16 variants, are needed to
clarify its anatomical site and syndrome tropism and the basis
for its impressive emergence and epidemic spread.
UTI-associated O antigen types were widely distributed
among the three sources studied, with signiﬁcant differences in
the syndrome-related distribution of certain O types. Of note,
three O types (O6, O25 and O75) were signiﬁcantly associ-
ated with pyelonephritis, suggesting that O typing could
contribute to intervention strategies.
Strengths of this study include the large number of well-
characterized cystitis, pyelonephritis and fecal isolates from
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the same geographical region and time period. This is
important because human-associated E. coli strains can vary
dramatically by region and over time [6,27]. Other strengths
include the extensive array of bacterial traits studied (including
identiﬁcation of the epidemic ST131 clonal group), and the
analysis of their distribution by phylogenetic group and
syndrome.
Study limitations include the use of multiple comparisons,
which can increase the chance of type one errors [28].
However, we regard our analysis as being exploratory and
hypothesis generating rather than deﬁnitive, requiring conﬁr-
mation in future studies.
Additionally, virulence was inferred based on molecular
traits, not in vivo assessment, and presence–absence testing for
a deﬁned set of genes risks overlooking other potentially
important determinants of cystitis and pyelonephritis, including
unrecognized VF genes [29], minor sequence variants of
known VFs [21], or differences in VF expression [30].
Finally, although our aim was to study uncomplicated UTI
without interference from the confounding effect of host
compromise, we cannot be certain that no patients had
signiﬁcant urinary tract abnormalities, because studies to rule
out structural or functional abnormalities were not performed.
However, patients were judged clinically to have uncomplicated
UTI based on the absence of known predisposing conditions.
In conclusion, our study, which to our knowledge is the ﬁrst
to compare E. coli isolates from men with cystitis or pyelo-
nephritis and from healthy fecal controls, from the same locale
and time period, identiﬁed a gradient of molecularly inferred
virulence, with pyelonephritis isolates appearing the most
virulent, followed closely by cystitis isolates, then distantly by
fecal isolates. The ST131 clonal group exhibited a similar
prevalence gradient, suggesting enhanced virulence compared
with other E. coli. These ﬁndings, which signiﬁcantly advance
our understanding of the distinctive E. coli strains that cause
UTI in men, may help in designing future diagnostic tests and
possibly preventive measures.
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